BOTTOSSO, MICHELE

BOTTOSSO, MICHELE  

Università di Padova  

Mostra records
Risultati 1 - 19 di 19 (tempo di esecuzione: 0.051 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
A comprehensive profiling of the immune microenvironment of breast cancer brain metastases 2022 Griguolo, GaiaTosi, AnnaDieci, Maria VittoriaVentura, AnnaveraBottosso, MicheleMiglietta, FedericaFassan, MatteoConte, PierFrancoRosato, AntonioGuarneri, Valentina + NEURO-ONCOLOGY - -
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 2023 Miglietta, FedericaGriguolo, GaiaBottosso, MicheleFassan, MatteoGuarneri, ValentinaDieci, Maria Vittoria + CLINICAL CANCER RESEARCH - -
Cardiac Safety of Adjuvant Trastuzumab and Paclitaxel for HER2+ early breast cancer patients published in Abstract Book of the 21th National Congress of Italian Association of Medical Oncology (AIOM) 25-27 October, 2019 - Rome, Italy Abstracts 2019 S. FrezziniT. GiarratanoG. GriguoloL. PiccinE. MioranzaA. MenichettiF. MigliettaE. GenovesiE. CumerlatoM. BottossoG. VernaciM. V. Dieci + TUMORI - -
Clinical applications of radiomics and deep learning in breast and lung cancer: A narrative literature review on current evidence and future perspectives 2024 Bottosso, MicheleDieci, Maria VittoriaMiglietta, FedericaBonanno, LauraGuarneri, ValentinaGriguolo, GaiaPasello, Giulia + CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY - -
Evolution of HER2-low expression from primary to recurrent breast cancer 2021 Miglietta F.Griguolo G.Bottosso M.Giarratano T.Fassan M.Cacciatore M.Genovesi E.De Bartolo D.Vernaci G.Amato O.Conte P. F.Guarneri V.Dieci M. V. + NPJ BREAST CANCER - -
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series 2022 Zarrilli G.Angerilli V.Cappellesso R.Galuppini F.Pennelli G.Farinati F.Nicole L.Savarino E.Griguolo G.Bottosso M.Dieci M. V.Guarneri V.Dei Tos A. P.Fassan M. + PATHOLOGY RESEARCH AND PRACTICE - -
Gene-expression assays to tailor adjuvant endocrine therapy for HR+/HER2- breast cancer 2024 Bottosso, MicheleMiglietta, FedericaDieci, Maria VittoriaGuarneri, ValentinaGriguolo, Gaia + CLINICAL CANCER RESEARCH - -
Gene-expression signatures to inform neoadjuvant treatment decision in HR+/HER2− breast cancer: Available evidence and clinical implications 2022 Griguolo G.Bottosso M.Vernaci G.Miglietta F.Dieci M. V.Guarneri V. CANCER TREATMENT REVIEWS - -
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment 2022 Federica MigliettaGaia GriguoloMichele BottossoTommaso GiarratanoMatteo FassanMatilde CacciatoreElisa GenovesiDebora De BartoloGrazia VernaciOttavia AmatoFrancesca PorraPierFranco ConteValentina GuarneriMaria Vittoria Dieci + NPJ BREAST CANCER - -
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial 2022 Guarneri, ValentinaDieci, Maria VittoriaGriguolo, GaiaMiglietta, FedericaBottosso, MicheleGiorgi, Carlo AlbertoConte, PierFranco + EBIOMEDICINE - -
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy 2021 Dieci M. V.Griguolo G.Bottosso M.Tsvetkova V.Giorgi C. A.Vernaci G.Tasca G.Genovesi E.Cumerlato E.Conte P. F.Guarneri V. + NPJ BREAST CANCER - -
Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohort 2022 Bottosso, MicheleDieci, Maria VittoriaGuarneri, ValentinaGriguolo, Gaia + INTERNATIONAL JOURNAL OF CANCER - -
Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival 2022 Miglietta, FBottosso, MGriguolo, GDieci, M VGuarneri, V ESMO OPEN - -
Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability? 2022 Miglietta, FedericaMarini, SabrinaGriguolo, GaiaVernaci, Grazia MariaBottosso, MicheleDieci, Maria VittoriaGuarneri, Valentina + CANCER TREATMENT REVIEWS - -
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study 2023 Miglietta, FedericaGriguolo, GaiaBottosso, MicheleDei Tos, Angelo PaoloGuarneri, ValentinaDieci, Maria VittoriaFassan, Matteo + JOURNAL OF CLINICAL PATHOLOGY - -
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases 2020 Di Liso, ElisabettaBottosso, MicheleTsvetkova, VassilenaDieci, Maria VittoriaMiglietta, FedericaTasca, GiuliaGiorgi, Carlo AlbertoGiarratano, TommasoMioranza, EleonoraDei Tos, Angelo PaoloConte, PierFrancoGuarneri, Valentina + ESMO OPEN - -
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases 2023 Bottosso, MicheleGriguolo, GaiaMiglietta, FedericaVernaci, GraziaGuarneri, ValentinaDieci, Maria Vittoria + BRITISH JOURNAL OF CANCER - -
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients 2023 Griguolo, GaiaBottosso, MicheleMiglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + INTERNATIONAL JOURNAL OF CANCER - -
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer 2020 Miglietta F.Dieci M. V.Tsvetkova V.Griguolo G.Vernaci G.Menichetti A.Faggioni G.Giarratano T.Mioranza E.Genovesi E.Cumerlato E.Bottosso M.Conte P.Guarneri V. + THE ONCOLOGIST - -